Dizal Completes Enrollment for Phase III Sunvozertinib NSCLC Study
Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus...